We are live on ! Find out more
SL

Siren LLC Portfolio holdings

AUM $3.61B
1-Year Est. Return 203.3%
This Fund
S&P 500
This Quarter Est. Return
+22.99%
1 Year Est. Return
+203.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2B
AUM Growth
–
Cap. Flow
+$1.96B
Cap. Flow %
97.94%
Top 10 Hldgs %
41.25%
Holding
112
New
112
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KYMR icon
Kymera Therapeutics
KYMR
+$131M
2
ONC
BeOne Medicines Ltd
ONC
+$101M
3
SRRK icon
Scholar Rock
SRRK
+$98.9M
4
APLS
Apellis Pharmaceuticals
APLS
+$80.3M
5
BCAX
Bicara Therapeutics
BCAX
+$78.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.5%
2 Technology 2.87%
3 Communication Services 1.83%
4 Consumer Discretionary 0.77%
5 Real Estate 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHL
101
DELISTED
Achilles Therapeutics
ACHL
$770K 0.04%
+755,375
New +$605K
DLTR icon
102
Dollar Tree
DLTR
$25.2B
$703K 0.04%
+10,000
New +$912K
NU icon
103
Nu Holdings
NU
$66.9B
$683K 0.03%
+50,000
New +$673K
ADBE icon
104
Adobe
ADBE
$105B
$518K 0.03%
+1,000
New +$548K
IRWD icon
105
Ironwood Pharmaceuticals
IRWD
$714M
$455K 0.02%
+110,532
New +$594K
BZ icon
106
Kanzhun
BZ
$7.36B
$434K 0.02%
+25,000
New +$364K
RELY icon
107
Remitly
RELY
$5.14B
$335K 0.02%
+25,000
New +$339K
CBIO
108
Crescent Biopharma
CBIO
$626M
$332K 0.02%
+19,651
New +$412K
CYCN icon
109
Cyclerion Therapeutics
CYCN
$16.7M
$301K 0.02%
+116,155
New +$342K
CRBU icon
110
Caribou Biosciences
CRBU
$164M
$206K 0.01%
+105,347
New +$216K
GOSS icon
111
CALL
Gossamer Bio
GOSS
$87M
$204K 0.01%
+207,000
New +$199K
PFTAW
112
CALL
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$3.8K ﹤0.01%
+126,666
New +$4.23K
1 2 3 4
5

Similar funds

SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
ACM
Advent Capital Management New York $3.63B AUM 0.29% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Siren LLC's Q3 2024 Portfolio in Review

Q3 2024 is the first quarter with a 13F filing on record for Siren LLC, which disclosed 112 positions worth $2B. Its ten largest holdings account for 41% of the portfolio.

Its largest position is Kymera Therapeutics: 2,969,733 shares worth $141M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, followed by Technology and Communication Services.

  • Siren LLC's largest Q3 2024 buy was Kymera Therapeutics: 2,969,733 shares worth $141M.
  • Siren LLC's ten largest holdings make up 41% of its $2B portfolio in Q3 2024.
  • Siren LLC disclosed 112 positions in Q3 2024, its first 13F filing on record.

Based on Siren LLC's 13F filing for Q3 2024, filed 13 Nov 2024.